Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06644846

Spatially Fractionated Radiation Treatment for Gynaecological Cancers

A Prospective Study of Spatially Fractionated Radiation Treatment Using Rapid Rod Technique for Gynaecological Cancers

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
20 (estimated)
Sponsor
Tata Memorial Hospital · Other Government
Sex
Female
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

This is a prospective study to evaluate in-field disease control, survival and late toxicity in patients with cervical cancer or pelvic recurrence treated with spatially fractionated RT. The study will include patients with primary cervical cancer or pelvic recurrence not suitable for brachytherapy in view of anticipated or actual suboptimal target coverage due to aberrant anatomy or large residual disease at the time of brachytherapy.

Detailed description

Patients will be treated with spatially fractionated radiation therapy (SFRT) after EBRT completion to a dose of 25-30 Gy in 5-6 fractions in the primary setting. For patients receiving re-irradiation, 20-25 Gy in 4-5 fractions will be delivered with SFRT, which however may be individualised to match with clinical practice in the re-RT setting. Total EQD2 Gy for organs at risk will be matched to brachytherapy. The study will be conducted at Tata Memorial Hospital, Mumbai and Advanced Centre for Treatment, Research and Education In Cancer (ACTREC), Navi Mumbai.

Conditions

Interventions

TypeNameDescription
RADIATIONSpatially fractionated radiation therapySpatially fractionated" radiation therapy (SFRT) enables delivery of high-dose radiation to discrete sub-volumes inside a tumour target while restricting the remainder of the target to a safer lower dose. This technique results in generation of intentionally heterogeneous dose distribution with spatial areas of "hot" and "cold" spots within the tumour, thereby sparing nearby organs at risk.

Timeline

Start date
2024-10-04
Primary completion
2027-02-28
Completion
2029-02-28
First posted
2024-10-16
Last updated
2026-02-20

Locations

1 site across 1 country: India

Source: ClinicalTrials.gov record NCT06644846. Inclusion in this directory is not an endorsement.